| 2021 | Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis | Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU ; DiBonaventura, Marco; Rojo, Ricardo; Antinew, Jeremias; Ionita, Ileana; Sinclair, Rodney; Forman, Seth; Zdybski, Jacek; Biswas, Pinaki; Malhotra, Bimal; Zhang, Fan; Valdez, Hernan | The New England journal of medicine | 143 | 129 | |
| 2022 | Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary | Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU ; DiBonaventura, Marco; et al., | Immunotherapy | 4 | 4 | |
| 2022 | Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis | Papp, Kim; Paul, Carle; Kleyn, C Elise; Huang, Yu-Huei; TSEN-FANG TSAI ; Schuster, Christopher; El Baou, Celine; Toth, Agoston; Riedl, Elisabeth; Mrowietz, Ulrich | Acta dermato-venereologica | 0 | 0 | |
